Connected Drug Delivery Devices Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
The market for connected medication delivery devices
market was
estimated to be worth USD 5.1 billion globally in 2024 and is expected to
expand at a compound annual growth rate (CAGR) of 23.4% over the course of the
forecast period. The market for linked drug delivery systems is driven by
rising health and hygiene consciousness. One of the main causes is the rising
incidence of diabetes, COPD, and asthma. Real-time data transfer between
devices and healthcare professionals is made possible by the integration of
technologies such as Bluetooth and Near Field Communication.
The market is
expanding as a result of rising healthcare costs and rising demand for early
diagnosis and treatment. Growing knowledge of chronic illnesses and how to
treat them is the main driver of the market's expansion. This market has been
significantly impacted by the pandemic.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/connected-drug-delivery-devices-market
Growth
Drivers
Global demand
for remote healthcare has surged due to the necessity of ongoing patient
monitoring. By supplying real-time data, connected medicine delivery systems
quickly speed up services and enable prompt interventions from medical
professionals. Increasing demand for individualized healthcare solutions is
propelling the expansion in the market substantially. This is made possible by
connected gadgets, which gather information that aids in therapy customization.
The market is
expanding as a result of rising demand for injectable devices to improve the
treatment of chronic illnesses. Furthermore, it is anticipated that the
introduction of smart injectable devices by numerous pharmaceutical companies
would present the injectable devices market with substantial growth prospects
over the course of the forecast year. Digital health solutions are being
promoted by the government's increased investment in healthcare infrastructure.
Segmentation
Product
Type Outlook
· Standalone
Components & Software integrated Devices
· Others
Route of
Administration Outlook
· Parenteral
· Inhalational
Application
Outlook
· Asthma
· COPD
· Diabetes
Management
· Others
By
Region
· Asia-Pacific
· North
America
· Latin
America
· Middle
East and Africa
· Europe
Key
Players
· Teva
Respiratory, LLC
· Novo
Nordisk A/S
· Phillips-Medisize,
LLC
· Medtronic
· Adherium
Limited
· Tandem
Diabetes Care, Inc.
· Biocorp
· Propeller
health
· Ypsomed
AG
· Aptar
Pharma
· Other
Players
For More Information about this Report @
https://www.xresearch.biz/shop/connected-drug-delivery-devices-market
About Us: -
xResearch is a market research and consulting
organization that uses unique data, expert analysis, and new technologies to
create trusted intelligence on industries. Our research is focused on
delivering an informed and impartial view on essential market data of industry,
and it is primarily driven by an in-depth study covering the following
parameters: Market Sizing and Forecasting, Market Segmentation, Competitive
Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment